Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novel isoquinoline anticonvulsants in development at SB

Nov. 4, 1998

Entropin concentrates its efforts on bringing Esterom to market

Nov. 4, 1998

Monoamine reuptake inhibitors especially useful for Parkinson's disease

Nov. 3, 1998

Positive CPMP opinion issued for Betaseron in new indication

Nov. 2, 1998

Licensing opportunity from the NIH: method of protecting neural cells from apoptosis

Nov. 2, 1998

Tacrolimus may represent novel neurotrophic strategy for neurodegenerative disorders

Oct. 30, 1998

Intravenous N-0923 associated with rapid onset and short-lasting antiparkinsonian effects

Oct. 30, 1998

Cytogen and Berlex enter into copromotion agreement for Quadramet

Oct. 30, 1998

Neuroprotective indolomorphinane derivatives under development at Toray

Oct. 30, 1998

Kappa-opioid antagonist MR-2266 is also an antagonist of ORL1 receptors

Oct. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026